Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Mutations in the Exon 12 of the JAK2 Gene Appeared To Be a Rare Event Essentially Clustered in V617F JAK2 Negative PV Patients.

Eirini Kouroupi, MD, Nathalie Parquet, MD, Christine Zoi, MD, Jean-Jacques Kiladjian, MD, Vassiliki Grigoraki, MD, Katerina Zoi, PhD, Linda Scott, PhD, Christine Dosquet, MD, Pierre Fenaux, MD, PhD, Dimitris Loukopoulos, MD, PhD, Christine Chomienne, MD, PhD, Bruno Cassinat, PharmD

Blood (2007) 110 (11): 2534.

https://doi.org/10.1182/blood.V110.11.2534.2534

Published: 2007

Journal Articles

Efficient Delivery of the A-Gamma Globin Gene in Human Hematopoietic and Non-Hematopoietic Cells by Cationic Phosphonolipid- and Lipophosphoramide-Mediated Transfection.

Daphne Koumbi, PhD, Jean C. Clement, PhD, Anna-Maria Psarra, PhD, Zili Sideratou, PhD, Jean-Jacques Yaouanc, PhD, Maria Chatzouli, BSc, Dimitris Loukopoulos, MD, Panagoula Kollia, PhD

Blood (2007) 110 (11): 5141.

https://doi.org/10.1182/blood.V110.11.5141.5141

Published: 2007

Journal Articles

Zoledronic Acid Is an Effective Treatment for Osteoporosis in Patients with Thalassemia Major: Results of a Randomized, Placebo-Controlled, Trial.

Ersi Voskaridou, MD, PhD, Dimitris Loukopoulos, MD, PhD, Eleni Stoupa, Eugenia Spyropoulou, John Meletis, Evangelos Terpos, MD, PhD

Blood (2005) 106 (11): 3656.

https://doi.org/10.1182/blood.V106.11.3656.3656

Published: 2005

Journal Articles

Osteoporosis in Sickle Cell/β-Thalassemia Is Primarily Caused by an Imbalance at the RANKL/OPG Pathway.

Ersi Voskaridou, MD, PhD, Ioannis Papassotiriou, PhD, Evangelos Premetis, PhD, John Meletis, MD, PhD, Dimitris Loukopoulos, MD, PhD, Evangelos Terpos, MD, PhD

Blood (2005) 106 (11): 3173.

https://doi.org/10.1182/blood.V106.11.3173.3173

Published: 2005

Journal Articles

Increased Expression of the PRV-1 Gene in Thalassemia Reflects the Rate of the Underlying Erythropoietic Activity.

Katerina Zoi, MSc, Christine Zoi, MSc, Ersi Voskaridou, MD, Evangelos Terpos, MD, Dimitris Loukopoulos, MD

Blood (2005) 106 (11): 2687.

https://doi.org/10.1182/blood.V106.11.2687.2687

Published: 2005

NARROW

Mutations in the Exon 12 of the JAK2 Gene Appeared To Be a Rare Event Essentially Clustered in V617F JAK2 Negative PV Patients.

Efficient Delivery of the A-Gamma Globin Gene in Human Hematopoietic and Non-Hematopoietic Cells by Cationic Phosphonolipid- and Lipophosphoramide-Mediated Transfection.

Zoledronic Acid Is an Effective Treatment for Osteoporosis in Patients with Thalassemia Major: Results of a Randomized, Placebo-Controlled, Trial.

Osteoporosis in Sickle Cell/β-Thalassemia Is Primarily Caused by an Imbalance at the RANKL/OPG Pathway.

Increased Expression of the PRV-1 Gene in Thalassemia Reflects the Rate of the Underlying Erythropoietic Activity.

Email alerts

ASH Publications

American Society of Hematology

Mutations in the Exon 12 of the JAK2 Gene Appeared To Be a Rare Event Essentially Clustered in V617F JAK2 Negative PV Patients.

Efficient Delivery of the A-Gamma Globin Gene in Human Hematopoietic and Non-Hematopoietic Cells by Cationic Phosphonolipid- and Lipophosphoramide-Mediated Transfection.

Zoledronic Acid Is an Effective Treatment for Osteoporosis in Patients with Thalassemia Major: Results of a Randomized, Placebo-Controlled, Trial.

Osteoporosis in Sickle Cell/β-Thalassemia Is Primarily Caused by an Imbalance at the RANKL/OPG Pathway.

Increased Expression of the PRV-1 Gene in Thalassemia Reflects the Rate of the Underlying Erythropoietic Activity.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only